Today: 10 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Concentrix (CNXC) Stock Jumps on Dec. 24, 2025: January Earnings Date, AI Product Push, and Analyst Forecasts

Concentrix (CNXC) Stock Jumps on Dec. 24, 2025: January Earnings Date, AI Product Push, and Analyst Forecasts

Concentrix shares closed up 3.6% at $41.60 in a holiday-shortened Dec. 24 session, with light trading volume. The stock remains near its 52-week lows, well below its mid-$60s peak. Investors are focused on the Jan. 13 earnings release and recent AI product launches. Wall Street sees potential upside if margins and debt improve.
24 December 2025
···
Abercrombie & Fitch (ANF) Stock on Dec. 24, 2025: Holiday-Shortened Rally, Analyst Targets, and the 2026 Outlook

Abercrombie & Fitch (ANF) Stock on Dec. 24, 2025: Holiday-Shortened Rally, Analyst Targets, and the 2026 Outlook

Abercrombie & Fitch shares nearly doubled from $65.61 on Nov. 24 to $126.78 at the Dec. 24, 2025 close, following a raised profit forecast and strong Hollister demand. The stock traded over 1 million shares in a holiday-shortened session, with market cap reaching $5.81 billion. ANF was among the highest dollar-volume apparel stocks, drawing traders’ attention amid record highs for U.S. indexes.
24 December 2025
··
CAVA Stock News Today (Dec. 24, 2025): Holiday-Shortened Rally, Analyst Targets, and What’s Next for CAVA Group (NYSE: CAVA)

CAVA Stock News Today (Dec. 24, 2025): Holiday-Shortened Rally, Analyst Targets, and What’s Next for CAVA Group (NYSE: CAVA)

CAVA shares closed at $62.10 on December 24, up 4.6% in a shortened session before Christmas, with volume near 2.3 million. The stock fell to $59.31 in after-hours trading, down about 4.5%. No new company disclosures were reported that day. Investors continue to weigh CAVA’s recent quarterly results and lowered full-year outlook.
24 December 2025
·
ICL Group Ltd Stock Rises on China Potash Contracts as Bartek Deal and Dead Sea Policy Risks Shape the 2026 Outlook (NYSE: ICL)

ICL Group Ltd Stock Rises on China Potash Contracts as Bartek Deal and Dead Sea Policy Risks Shape the 2026 Outlook (NYSE: ICL)

ICL Group shares rose about 3.3% to $5.35 on Dec. 24, 2025, after the company disclosed new potash supply contracts with China at $348 per ton and progress on its Bartek Ingredients acquisition. Investors also weighed ongoing legal and regulatory developments affecting ICL’s Dead Sea operations, including a Supreme Court water-fee ruling and draft mineral extraction legislation.
24 December 2025
·
Nike Stock News (NKE) on Dec. 24, 2025: Tim Cook’s Insider Buy Sparks Rally as Wall Street Reassesses the Turnaround

Nike Stock News (NKE) on Dec. 24, 2025: Tim Cook’s Insider Buy Sparks Rally as Wall Street Reassesses the Turnaround

Nike shares rose about 5% to $60 in a shortened session Dec. 24 after SEC filings showed Apple CEO Tim Cook bought nearly $3 million in Nike stock on Dec. 22. Cook, Nike’s lead independent director, purchased 50,000 shares at around $58.97 each. Director Robert Swan also bought 8,691 shares. The insider buying followed Nike’s fiscal Q2 earnings release.
24 December 2025
··
Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

Shinhan Financial Group’s Korea-listed shares closed at ₩77,800 on Dec. 24, up 1.7% even as the KOSPI slipped 0.21%. South Korea’s financial regulator announced an emergency inspection of Shinhan Card after a data leak affecting over 190,000 merchant operator records. The company said the breach was not caused by hacking and involved non-sensitive data. U.S.-listed ADRs traded near $54.
24 December 2025
···
Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Advance Auto Parts traded around $40–$41 on Dec. 24 after a volatile month, rebounding from recent lows. The company named Ronald Gilbert as Senior Vice President of Supply Chain, effective Dec. 22. Shares remain far below the 52-week high, with investors watching turnaround efforts and sector pricing pressures. A $0.25 quarterly dividend was declared, payable Jan. 23, 2026.
24 December 2025
·
Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology shares hit a record high near $289 during the shortened Christmas Eve session after reporting Q1 2026 revenue of $13.64 billion and strong guidance for Q2. The company projected $18.7 billion in revenue and 68% gross margin for next quarter, citing tight memory supply driven by AI data center demand. Analysts issued upgrades, with Rosenblatt setting a $500 price target.
24 December 2025
···
POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

POSCO Holdings shares closed at KRW 314,000 in Seoul on Dec. 24, up 3.29%, after its battery materials unit, POSCO Future M, signed a joint venture with CNGR to build an LFP cathode plant in Pohang. Construction starts in 2026, with mass production set for 2027 and a planned capacity of up to 50,000 tons per year. POSCO’s NYSE ADR traded near $54.56.
24 December 2025
·
Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global shares rose 4.36% to near $19.15 by midday December 24, 2025, in a thinly traded, early-closing session. The move followed a gap-up open and heavy options activity, with investors reacting to the company’s raised 2025–2026 outlook after its $325 million Marigold enterprise acquisition. Major indexes hovered near record highs. No new company headlines were issued during the session.
24 December 2025
··
Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

Almonty Industries delivered first ore to the ROM pad at its Sangdong tungsten mine in South Korea, marking the shift to active mining. The company’s Nasdaq shares traded in the mid-$9 range Dec. 24 after raising $129.4 million in U.S. equity financing. Sangdong concentrator commissioning is now set for 2026, with commercial production targeted for the first half of the year.
24 December 2025
·
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

China’s NMPA approved Zai Lab’s COBENFY for adult schizophrenia on Dec. 23, triggering a surge in Zai Lab shares. The U.S. ADR traded around $18.54 intraday, while Hong Kong shares closed at HK$14.48, up 6.24%. COBENFY is the first M1/M4 muscarinic receptor therapy for schizophrenia approved in China. Zai Lab holds exclusive commercialization rights in Greater China.
24 December 2025
···
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences shares traded around $18.1–$18.5 on December 24, 2025, holding gains after positive WVE-007 obesity data and a recent capital raise. No new company news crossed the wire, but analysts raised fair value targets following the Phase 1 results showing reduced visceral fat and increased lean mass. At least one after-hours trade printed below the regular close amid thin holiday volume.
24 December 2025
··
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics shares jumped about 15% to over $40 in early trading on Dec. 24, 2025, hitting new highs during a holiday-shortened session. The surge followed investor anticipation of an FDA decision on FILSPARI for FSGS, expected by Jan. 13, 2026. No company news was released that day. The FDA previously waived an advisory committee review for the application.
24 December 2025
·
Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar shares surged about 13% to $17.09 on December 24, 2025, after announcing a $300 million equity investment from BBVA and Natixis, plus a $300 million debt-to-equity conversion with Geely. Trading volume topped 200,000 shares. The moves aim to boost liquidity and address debt concerns as the company faces EV market pressures.
24 December 2025
··
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics shares jumped 21% to $26.37 intraday Wednesday after the company reported positive interim safety data for its EDG-7500 therapy in hypertrophic cardiomyopathy. The update showed no clinically meaningful LVEF reductions and no LVEF drops below 50% among 20 patients, with one new-onset atrial fibrillation event disclosed. Over 40 participants have enrolled in Part D of the trial.
24 December 2025
··
Recursion Pharmaceuticals (RXRX) Stock News Today: Analysts Refocus on REC-4881 Data, ARK Buying, and a 2026 CEO Transition

Recursion Pharmaceuticals (RXRX) Stock News Today: Analysts Refocus on REC-4881 Data, ARK Buying, and a 2026 CEO Transition

Recursion Pharmaceuticals shares traded near $4.37 on December 24, 2025, after J.P. Morgan upgraded the stock and Cathie Wood’s ARK funds increased their position. Trading volume was in the low millions during the early-close Christmas Eve session. The moves follow positive clinical data from REC-4881’s Phase 1b/2 trial in FAP. RXRX’s market cap stands at roughly $2.12 billion.
24 December 2025
·
Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics agreed to be acquired for $24.55 per share in cash, valuing the company at about $8.4 billion including debt. CWAN shares traded at $24.14 on December 24, 2025, reflecting the pending deal. The merger includes a go-shop period through January 23, 2026, allowing Clearwater to seek alternative offers.
24 December 2025
··
1 … 379 380 381 382 383 … 584
Go toTop